Lung Cancer

This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lung cancer treatment. Lung cancer treatment has undergone major changes over the course of the past few years and the pace of new research and development is expected to continue at a high level for the immediate future. Lung Cancer addresses current best practices in the light of the most recent evidence and new developments in this field. All of the chapters are written by international experts in the field, address the common clinical scenarios in Lung cancer and are multidisciplinary in scope. Coverage includes discussion of prevention, screening, surgery, radiation therapy, chemotherapy, immunotherapy, new therapeutic approaches, and more.

Emerging Cancer Therapeutics features:

• Editorial board of nationally recognised experts across the spectrum of Cancer Therapeutics
• In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Cancer Therapeutics
• Issues edited by an authority in specific subject area
• Focuses on major topics in Cancer Therapeutics with in-depth articles covering advances in clinical and translational research developments, as well as clinical applications and experience
• Emphasises multidisciplinary approaches to research and practice
<